Intermediate dose of nonpegylated liposomal doxorubicin combination (R-CMyOP) as first line chemotherapy for frail elderly patients with aggressive lymphoma.
暂无分享，去创建一个
A. Salar | J. Comín | C. Besses | B. Sánchez‐González | E. Abella | A. Álvarez-Larrán | C. Pedro | S. Saumell | Miquel Gómez | E. Gimeno | F. García-Pallarols | F. García‐Pallarols | M. Gómez